NeoGenomics Inc. shared a strong financial outlook for 2025 and beyond. The Fort Myers-based cancer testing and research lab ...

NeoGenomics' Chris Smith will retire as CEO and board member, effective April 1, 2025. Tony Zook will assume the role of CEO ...

NeoGenomics (NEO) announced that Chris Smith will retire as CEO and board member effective April 1. Tony Zook, an independent board member ...

NeoGenomics said its chief executive, Chris Smith, plans to retire April 1. The Fort Myers, Fla., oncology testing services company on Friday said Tony Zook, an independent board member since 2023, ...

Shares of NeoGenomics, Inc. (NASDAQ: NEO) are, after the company announced that CEO Chris Smith will retire effective April 1 ...

At that time, Tony Zook, an independent board member, will assume the role of CEO. He's been on the board since 2023. Shares fell by more than 17% on the news of a leadership change. To ensure ...

Tony Zook, an independent board member since 2023, will assume the role of CEO at that time. “Chris has provided exceptional leadership for NeoGenomics, joining the Company at a critical time ...

Tony Zook, who has been on the NeoGenomics board since mid-2023, brings leadership experience, including a stint as a public company CEO that concluded with a company sale. However, his experience ...